MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MOH - US60855R1005 - Common Stock
184.73 USD
+1.93 (+1.06%)
185.01 USD
+0.28 (+0.15%)
Taking everything into account, MOH scores 5 out of 10 in our fundamental rating. MOH was compared to 101 industry peers in the Health Care Providers & Services industry. MOH has only an average score on both its financial health and profitability. MOH has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
MOH had positive earnings in the past year.
In the past year MOH has reported a negative cash flow from operations.
In the past 5 years MOH has always been profitable.
MOH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
MOH has a Return On Assets of 5.62%. This is amongst the best in the industry. MOH outperforms 80.20% of its industry peers.
The Return On Equity of MOH (21.07%) is better than 88.12% of its industry peers.
The Return On Invested Capital of MOH (11.98%) is better than 86.14% of its industry peers.
MOH had an Average Return On Invested Capital over the past 3 years of 17.96%. This is significantly above the industry average of 9.21%.
The 3 year average ROIC (17.96%) for MOH is well above the current ROIC(11.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROIC | 11.98% |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
1.3 Margins
The Profit Margin of MOH (1.98%) is better than 61.39% of its industry peers.
MOH's Profit Margin has declined in the last couple of years.
The Operating Margin of MOH (2.97%) is comparable to the rest of the industry.
MOH's Operating Margin has declined in the last couple of years.
MOH has a Gross Margin of 13.91%. This is in the lower half of the industry: MOH underperforms 66.34% of its industry peers.
In the last couple of years the Gross Margin of MOH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% |
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
2. Health
2.1 Basic Checks
MOH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MOH has less shares outstanding
Compared to 5 years ago, MOH has less shares outstanding
Compared to 1 year ago, MOH has a worse debt to assets ratio.
2.2 Solvency
MOH has an Altman-Z score of 4.33. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
MOH has a better Altman-Z score (4.33) than 78.22% of its industry peers.
A Debt/Equity ratio of 0.92 indicates that MOH is somewhat dependend on debt financing.
MOH has a Debt to Equity ratio (0.92) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.33 |
ROIC/WACC1.41
WACC8.47%
2.3 Liquidity
A Current Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
MOH's Current ratio of 1.68 is fine compared to the rest of the industry. MOH outperforms 65.35% of its industry peers.
A Quick Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.68, MOH is in the better half of the industry, outperforming 70.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
The earnings per share for MOH have decreased strongly by -16.06% in the last year.
The Earnings Per Share has been growing by 14.16% on average over the past years. This is quite good.
MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.65%.
The Revenue has been growing by 19.29% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
3.2 Future
MOH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.82% yearly.
MOH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.46% yearly.
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y4.82%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y5.46%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.01 indicates a reasonable valuation of MOH.
Based on the Price/Earnings ratio, MOH is valued cheaply inside the industry as 93.07% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.17, MOH is valued rather cheaply.
With a Price/Forward Earnings ratio of 13.50, MOH is valued correctly.
Based on the Price/Forward Earnings ratio, MOH is valued cheaply inside the industry as 81.19% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MOH to the average of the S&P500 Index (23.79), we can say MOH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.01 | ||
| Fwd PE | 13.5 |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than MOH, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.38 |
4.3 Compensation for Growth
The decent profitability rating of MOH may justify a higher PE ratio.
A cheap valuation may be justified as MOH's earnings are expected to decrease with -10.35% in the coming years.
PEG (NY)N/A
PEG (5Y)0.71
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
5. Dividend
5.1 Amount
No dividends for MOH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
184.73
+1.93 (+1.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners113.06%
Inst Owner Change0%
Ins Owners1.33%
Ins Owner Change1.17%
Market Cap9.50B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts56.3
Price Target172.29 (-6.73%)
Short Float %7.14%
Short Ratio1.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-2.48%
PT rev (3m)-16.03%
EPS NQ rev (1m)-34.65%
EPS NQ rev (3m)-89.71%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-23.58%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.01 | ||
| Fwd PE | 13.5 | ||
| P/S | 0.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.27 | ||
| P/tB | 4.77 | ||
| EV/EBITDA | 0.38 |
EPS(TTM)18.45
EY9.99%
EPS(NY)13.69
Fwd EY7.41%
FCF(TTM)-11.17
FCFYN/A
OCF(TTM)-8.97
OCFYN/A
SpS866.73
BVpS81.54
TBVpS38.7
PEG (NY)N/A
PEG (5Y)0.71
Graham Number183.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROCE | 16.11% | ||
| ROIC | 11.98% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% | ||
| FCFM | N/A |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 56.78% | ||
| Cap/Sales | 0.25% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 4.33 |
F-Score4
WACC8.47%
ROIC/WACC1.41
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y4.82%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y5.46%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-31.25%
EBIT Next 3Y-9.54%
EBIT Next 5YN/A
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%
MOLINA HEALTHCARE INC / MOH FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 5 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 5 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for MOH stock?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 10.01 and the Price/Book (PB) ratio is 2.27.